Pablo Guzman - Jan 26, 2023 Form 3 Insider Report for ZyVersa Therapeutics, Inc. (ZVSA)

Role
Chief Medical Officer
Signature
/s/ Pablo Guzman
Stock symbol
ZVSA
Transactions as of
Jan 26, 2023
Transactions value $
$0
Form type
3
Date filed
1/26/2023, 07:22 PM

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding ZVSA Common Stock 26K Jan 26, 2023 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding ZVSA Stock Option (Right to Buy) Jan 26, 2023 Common Stock 2.98K $5.03 Direct
holding ZVSA Stock Option (Right to Buy) Jan 26, 2023 Common Stock 9.93K $5.03 Direct F1
holding ZVSA Stock Option (Right to Buy) Jan 26, 2023 Common Stock 19.9K $11.58 Direct F2
holding ZVSA Stock Option (Right to Buy) Jan 26, 2023 Common Stock 11K $16.36 Direct
holding ZVSA Stock Option (Right to Buy) Jan 26, 2023 Common Stock 2.91K $16.36 Direct
holding ZVSA Stock Option (Right to Buy) Jan 26, 2023 Common Stock 4.37K $16.36 Direct
holding ZVSA Stock Option (Right to Buy) Jan 26, 2023 Common Stock 4.37K $16.36 Direct
holding ZVSA Stock Option (Right to Buy) Jan 26, 2023 Common Stock 4.37K $16.36 Direct
holding ZVSA Stock Option (Right to Buy) Jan 26, 2023 Common Stock 4.37K $16.36 Direct
holding ZVSA Stock Option (Right to Buy) Jan 26, 2023 Common Stock 4.37K $16.36 Direct
holding ZVSA Stock Option (Right to Buy) Jan 26, 2023 Common Stock 4.37K $11.33 Direct
holding ZVSA Warrant (Right to Buy) Jan 26, 2023 Common Stock 9.02K $6.90 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 100% of the option is immediately exercisable. The option vested in 3 equal annual installments commencing on January 22, 2016.
F2 100% of the option is immediately exercisable. The option vested in 3 equal annual installments commencing on April 1, 2020.

Remarks:

Exhibit 24- Power of Attorney